Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model
about
Invariant NKT cells as novel targets for immunotherapy in solid tumorsPD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.The Response of CD1d-Restricted Invariant NKT Cells to Microbial Pathogens and Their ProductsNovel anti-melanoma immunotherapies: disarming tumor escape mechanisms.Promise of cancer stem cell vaccine.Targeting costimulatory molecules to improve antitumor immunity.PD-L1-specific T cells.Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells.PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.Mixed Signals: Co-Stimulation in Invariant Natural Killer T Cell-Mediated Cancer Immunotherapy.Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy.Functional Invariant Natural Killer T Cells Secreting Cytokines Are Associated With Non-Progressive Human Immunodeficiency Virus-1 Infection but Not With Suppressive Anti-Retroviral Treatment.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.Therapeutic Potential of Invariant Natural Killer T Cells in Autoimmunity.
P2860
Q21284987-613BF1E1-933B-415E-9CCF-9C1E4C0E4368Q33839204-54AB61AF-1BBB-4071-8570-159DEAB4FF5EQ34566554-24D6696E-9D87-43EE-B9B7-44251BE2BD09Q35600087-06937600-0597-47BF-9697-C7F910354F2FQ36067524-D378CEE9-09F8-48DE-AAA6-2CDF6BEEE0F6Q37320126-0B24F0FE-7834-4E2B-85B6-6E3A5CDD906FQ38002404-DE7F49C5-1D10-49DF-909C-BACDDF3451CBQ38685359-B5FBE151-A30A-4858-B6CB-211EF309FD69Q38955079-513B8513-49B9-44E0-BBF8-17F8C4D62D50Q42271423-FFD877BB-973F-4B66-B3AA-36883E474C80Q47094171-47D6D712-8EF1-4380-A266-041141A1EDACQ50075685-9791E535-F95C-4B9D-A339-9C14484FC87EQ55000980-E9BAAEC6-28E8-49AC-9377-C57147DF3A47Q55174561-FB72E948-6EE1-4DA1-8301-72F47235E57EQ55280646-B84BA578-9C18-4188-B895-E36AE99E10D7
P2860
Targeting NKT cells and PD-L1 pathway results in augmented anti-tumor responses in a melanoma model
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@ast
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@en
type
label
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@ast
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@en
prefLabel
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@ast
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@en
P2093
P2860
P1476
Targeting NKT cells and PD-L1 ...... responses in a melanoma model
@en
P2093
Kevin Durgan
Mohamed Ali
Paul Warner
Yvette E Latchman
P2860
P2888
P304
P356
10.1007/S00262-010-0963-5
P577
2011-01-15T00:00:00Z